Related Experiment Video
Updated: Jul 22, 2025
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Ectopic expression of neuronal adenosine kinase, a biomarker in mesial temporal lobe epilepsy without hippocampal
Mengyi Guo1, Jing Wang1, Zhonghua Xiong1
1Department of Brain Institute, Center of Epilepsy, Beijing Institute for Brain Disorders, Beijing Key Laboratory of Epilepsy Research, Sanbo Brain Hospital, Capital Medical University, Beijing, China.
Aims:
Mesial temporal lobe epilepsy without hippocampal sclerosis (no-HS MTLE) refers to those MTLE patients who have neither magnetic resonance imaging (MRI) lesions nor definite pathological evidence of hippocampal sclerosis. They usually have resistance to antiepileptic drugs, difficulties in precise seizure location and poor surgical outcomes. Adenosine is a neuroprotective neuromodulator that acts as a seizure terminator in the brain. The role of adenosine in no-HS MTLE is still unclear. Further research to explore the aetiology and pathogenesis of no-HS MTLE may help to find new therapeutic targets.
Methods:
In surgically resected hippocampal specimens, we examined the maladaptive changes of the adenosine system of patients with no-HS MTLE. In order to better understand the dysregulation of the adenosine pathway in no-HS MTLE, we developed a rat model based on the induction of focal cortical lesions through a prenatal freeze injury.
Results:
We first examined the adenosine system in no-HS MTLE patients who lack hippocampal neuronal loss and found ectopic expression of the astrocytic adenosine metabolising enzyme adenosine kinase (ADK) in hippocampal pyramidal neurons, as well as downregulation of neuronal A1 receptors (A1 Rs) in the hippocampus. In the no-HS MTLE model rats, the transition of ADK from neuronal expression to an adult pattern of glial expression in the hippocampus was significantly delayed.
Conclusions:
Ectopic expression of neuronal ADK might be a pathological hallmark of no-HS MTLE. Maladaptive changes in adenosine metabolism might be a novel target for therapeutic intervention in no-HS MTLE.
Insights
Mesial temporal lobe epilepsy without hippocampal sclerosis (no-HS MTLE) involves abnormal adenosine system changes, including ectopic adenosine kinase expression and reduced A1 receptors. These findings suggest adenosine metabolism as a potential therapeutic target for drug-resistant epilepsy.
Area of Science:
- Neuroscience
- Epilepsy Research
- Molecular Biology
Background:
- Mesial temporal lobe epilepsy without hippocampal sclerosis (no-HS MTLE) presents challenges in treatment and surgical outcomes due to unclear etiology.
- Adenosine, a key neuromodulator, plays a role in seizure termination, but its involvement in no-HS MTLE remains largely unexplored.
- Understanding the adenosine system's dysfunction in no-HS MTLE is crucial for identifying novel therapeutic strategies.
Purpose of the Study:
- To investigate the maladaptive changes in the adenosine system within the hippocampus of patients with no-HS MTLE.
- To develop and utilize a rat model to elucidate the dysregulation of the adenosine pathway in no-HS MTLE.
- To identify potential pathological hallmarks and therapeutic targets related to adenosine metabolism in no-HS MTLE.
Main Methods:
- Analysis of surgically resected hippocampal specimens from no-HS MTLE patients.
- Development of a rat model for no-HS MTLE using prenatal freeze injury to induce focal cortical lesions.
- Examination of adenosine system components, including adenosine kinase (ADK) expression and A1 receptor (A1R) levels.
Main Results:
- Patients with no-HS MTLE exhibited ectopic expression of adenosine kinase (ADK) in hippocampal pyramidal neurons and downregulated neuronal A1 receptors (A1Rs).
- In the no-HS MTLE rat model, the normal developmental shift of ADK expression from neuronal to glial cells in the hippocampus was significantly delayed.
- These findings indicate specific alterations in adenosine metabolism and receptor function in the absence of hippocampal sclerosis.
Conclusions:
- Ectopic neuronal expression of adenosine kinase (ADK) may serve as a distinctive pathological marker for no-HS MTLE.
- Dysregulation within the adenosine metabolic pathway represents a promising novel therapeutic target for no-HS MTLE.
- Further research into the adenosine system could lead to improved treatments for patients with drug-resistant epilepsy.
